Neurology Archives 1. Harrison DM, Newsome SD, Skolasky RL, McArthur
JC, Nath A. Immune reconstitution is not a prognostic factor in progressive
multifocal leukoencephalopathy. J. Neuroimmunol. 2011 Sep 15;238(1-2):81-6. 2. Hinson HE, Melnychuk E, Muschelli J, Hanley
DF, Awad IA, Ziai WC. Drainage efficiency with dual versus single catheters
in severe intraventricular hemorrhage. Neurocrit Care. 2011 Jun 17.
[Epub ahead of print] 3. Tan IL, Koralnik IJ, Rumbaugh JA, Burger
PC, King-Rennie A, McArthur, JC. Progressive multifocal leukoencephalopathy
in a patient without immunodeficiency. Neurology. 2011 Jul 19;77(3):297-9.
1. Andrabi SA, Kang
HC, Haince JF, Lee YI, Zhang J, Chi Z, West AB, Koehler RC, Poirier
GG, Dawson TM, Dawson VL. Iduna protects the brain from glutamate excitotoxicity
and stroke by interfering with poly(ADP-ribose) polymer-induced cell
death. Nat Med. 2011 Jun;17(6):692-9. Epub 2011 May 22. 2. Brown A, Islam T,
Adams R, Nerle S, Kamara M, Eger C, Marder K, Cohen B, Schifitto G,
McArthur JC, Sacktor N, Pardo CA. Osteopontin enhances HIV Replication
and is increased in the brain and cerebrospinal fluid of HIV infected
individuals. J Neurovirol. 2011;May 10 [ePub ahead of print]. 3. Cervenka MC, Hartman
AL, Venkatesan A, Geocadin RG, Kossoff EK. The ketogenic diet for medically
and surgically refractory status epilepticus in the Neurocritical Care
Unit. Neurocrit Care. 2011 Apr 27 [ePub ahead of print]. 4. Huang VS, Haith
A, Mazzoni P, Krakauer JW. Rethinking motor learning and savings in
adaptation paradigms: model-free memory for successful actions combines
with internal models. Neuron. 2011 May 26;70(4):787-801. 5. Kaplan PW, Rossetti
AO. EEG patterns and imaging correlations in encephalopathy: encephalopathy
part II. J Clin Neurophysiol. 2011 Jun;28(3):233-51. 6. Korzeniewska A, Franaszczuk PJ, Crainiceanu
CM, Ku? R, Crone, N. Dynamics of large-scale cortical interactions at
high gamma frequencies during word production: Event related causality
(ERC) analysis of human electrocorticography (ECoG). NeuroImage. 2011
Jun 15;56(4):2218-37. 7. Moghekar A, Rao S, Li M, Ruben D, Mammen A,
Tang X, O'Brien RJ. Large quantities of A? peptide are constitutively
released during amyloid precursor protein metabolism in vivo and in
vitro.J Biol Chem. 2011 May 6;286(18):15989-97. 8. Schambra HM, Abe M, Luckenbaugh DA, Reis J,
Krakauer JW, Cohen LG. Probing for hemispheric specialization for motor
skill learning: a transcranial direct current stimulation study. J Neurophysiol.
2011 May 25. [Epub ahead of print] 9. Zarahn E, Alon L, Ryan SL, Lazar RM,
Vry MS, Weiller C, Marshall RS, Krakauer JW. Prediction of motor recovery
using initial impairment and fMRI 48 h poststroke. Cereb Cortex. 2011
Apr 28. 10. Zhang J, Wang Y, Chi Z, Keuss MJ, Pai
YM, Kang HC, Shin JH, Bugayenko A, Wang H, Xiong Y, Pletnikov MV, Mattson
MP, Dawson TM, Dawson VL. The AAA+ ATPase Thorase regulates AMPA receptor-dependent
synaptic plasticity and behavior.Cell. 2011 Apr 15;145(2):284-99. 1. Ostrow LW, Kaplan
PW. Tonic Status and electrodecremental paroxysms in an adult without
epilepsy. Epileptic Disorders. 2011; 13(1):99-101. 2. Shin JH, Ko HS, Kang H, Lee Y, Lee YI,
Pletinkova O, Troconso JC, Dawson VL, Dawson PARIS (ZNF746) repression
of PGC-1? contributes to neurodegeneration in Parkinson's Disease. TM.Cell.
2011 Mar 4;144(5):689-702. 1. Cettomai D, Hiremath G, Ratchford J, Venkatesan
A, Greenberg BM, McGready J, Pardo CA, Kerr DA, Frohman E, Balcer LJ,
McArthur JC, Calabresi PA. Associations between retinal nerve fiber
layer abnormalities and optic nerve examination. Neurology. 2010 Oct
12;75(15): 1318-25. 2. Jones DT, Mateen FJ, Lucchinetti CF, Jack CR
Jr, Welker KM. Default mode network disruption secondary to a lesion
in the anterior thalamus. Arch Neurol. 2010 Oct 11. [Epub ahead of print]
4. Mateen FJ, Cascino GD. Khat chewing: a smokeless
gun? Mayo Clin Proc 2010;85:971-3. 7. Mateen FJ. Neurological disorders in complex
humanitarian emergencies and natural disasters. 8. Mateen FJ, Carone M, Sorenson EJ. Patients
who survive 5 years or more with ALS in Olmsted County, 1925-2004. J
Neurol Neurosurg Psychiatry. 2010 Oct;81(10):1144-6. 9. Mateen FJ, Boes CJ. "Pinheads": The
exhibition of neurological disorders at "The Greatest Show on Earth."
Neurology 2010;75:2028-32. 10. Rojas C, Zhang LY, Stathis MJ, Alt J, Thomas
AG, Cantoreggi S, Sebastiani S, Pietra C, Slusher BS. The antiemetic
5-HT3 receptor antagonist Palonosetron inhibits Substance P-mediated
responses in vitro and in vivo. J Pharmacol Exp Ther.; 2010 Nov; 335(2):362-8. 11. Seltzer MJ, Joshi AD, Gao P, Tsukamoto T,
Ferraris D, Rojas C, Thomas A, Slusher BS, Dang CV, Riggins GJ. Inhibition
of glutaminase preferentially slows growth of glioma cells with mutant
IDH1. Cancer Res. 2010 Nov 15;70(22):8981-7. 12. Wozniak KM, Lapidus RG, Wu Y, Carozzi
V, Cavaletti G, Hayakawa K, Towle M, Littlefield BA, Nomoto K, Slusher
BS. Assessment of neuropathy-inducing effects of eribulin mesylate versus
paclitaxel and ixabepilone in mice. Annals of Oncology 2010 Oct; 21(Suppl
8): viii 57. 1. Marvel CL, Desmond
JE. Functional topography of the cerebellum in verbal working memory.
Neuropsychol Rev. 2010 Jun 22. [Epub ahead of print]. 1. Barbon CM, Yang M, Wands GD, Ramesh R, Slusher
BS, Hedley ML, Luby TM. Consecutive low doses of cyclophosphamide preferentially
target Tregs and potentiate T cell responses induced by DNA PLG microparticle
immunization. Cellular Immunology. 2010;262(2):150-61. Epub 2010 Feb
12. 2. Cherry CL, Affandi JS, Brew BJ, Creighton J,
Djauzi S, Hooker DJ, Imran D, Kamarulzman A, Kamerman P, McArthur JC,
Moore, RD, Price P, Smyth K, Tan IL, Vanar S, Wadley A, Wesselingh SL,
Yunihastuti E. Hepatitis C seropositivity is not a risk factor for sensory
neuropathy among patients with HIV. Neurology. 2010 May 11;74(19):1538-42. 3. Clifford D, De Luca A, Simpson D, Arendt G,
Giovanni G, Nath A. Natalizumab associated progressive multifocal leukoencephalopathy:
lessons from early cases. Lancet Neurology. 2010 Apr;9(4):438-46. 4. Drel VR, Lupachyk S, Shevalye H, Vareniuk I,
Weizheng X, Zhang J, Delamere NA, Shahidullah M, Slusher BS, Obrosova
IG. New therapeutic and biomarker discovery for peripheral diabetic
neuropathy: PARP inhibitor, nitrotyrosine, and TNF-a. Endocrinology.
2010 Jun;151(6):2547-55. 5. Ellis RJ, Rosario D, Clifford DB, McArthur
JC, Simpson D, Alexander T, Gelman BB, Vaida F, Collier A, Marra CM,
Ances B, Atkinson JH, Dworkin RH, Morgello S, Grant I; for the CHARTER
Study Group. Continued high prevalence and adverse clinical impact of
human immunoceficiency virus-associated sensory neuropathy in the era
of combination antiretroviral therapy: the CHARTER study. Arch Neurol.
May 2010 67(5) 552-558. 6. Ferraris,D. Evolution of Poly(ADP-ribose) Polymerase-1
(PARP-1) Inhibitors, from concept to clinic. Journal of Medicinal Chemistry.
2010 Apr. 5. [Epub ahead of print] 7. Höke A, Brushart T. Introduction to special
issue: Challenges and opportunities for regeneration in the peripheral
nervous system. Exp Neurol. 2010 May;223(1):1-4. 8. Kossoff EH. Infantile spasms. Neurologist.
2010 Mar;16(2):69-75. 9. Vyas A, Li Z, Aspalter M, Feiner J, Hoke A,
Zhou C, O'Daly A, Abdullah M, Rohde C, Brushart TM. An in vitro model
of adult mammalian nerve repair. Exp Neurol. 2010 May;223(1):112-8.
10. Wang, T, Lee, M, Alie, R, Hu, L, Calabresi
P, Nath A. Activated T cells inhibit neurogenesis by releasing granzyme
B: rescue by Kv1.3 blockers. J. Neuroscience. 2010 Apr 7;30(14):5020-7. Return to top of Publications - Neurology Archives
|
|
||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
JHM Appointments | Employment @ JHM | Finding a Doctor | Disclaimer | Maps & Directions | Contact JHM |
|
|